Phillipe N. Nyambi - Publications

Affiliations: 
Basic Medical Science New York University, New York, NY, United States 
Area:
Microbiology Biology

75 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Tuen M, Bimela JS, Banin AN, Ding S, Harkins GW, Weiss S, Itri V, Durham AR, Porcella SF, Soni S, Mayr L, Meli J, Torimiro JN, Tongo M, Wang X, ... ... Nyambi PN, et al. Immune Correlates of Disease Progression in Linked HIV-1 Infection. Frontiers in Immunology. 10: 1062. PMID 31139189 DOI: 10.3389/Fimmu.2019.01062  0.512
2019 Banin AN, Tuen M, Bimela JS, Tongo M, Zappile P, Khodadadi-Jamayran A, Nanfack AJ, Meli J, Wang X, Mbanya D, Ngogang J, Heguy A, Nyambi PN, Fokunang C, Duerr R. Development of a Versatile, Near Full Genome Amplification and Sequencing Approach for a Broad Variety of HIV-1 Group M Variants. Viruses. 11. PMID 30939815 DOI: 10.3390/V11040317  0.569
2017 Lynch B, Patel EU, Courtney CR, Nanfack A, Bimela J, Wang X, Eid I, Quinn TC, Laeyendecker O, Nyambi PN, Duerr R, Redd A. False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm among Cameroonians with Long-term HIV infection. Aids Research and Human Retroviruses. PMID 28670965 DOI: 10.1089/Aid.2017.0084  0.535
2017 Nanfack AJ, Redd AD, Bimela JS, Ncham G, Achem E, Banin AN, Kirkpatrick AR, Porcella SF, Agyingi LA, Meli J, Colizzi V, Nádas A, Gorny MK, Nyambi PN, Quinn TC, et al. Multimethod Longitudinal HIV Drug Resistance Analysis in ART Naïve Patients. Journal of Clinical Microbiology. PMID 28659324 DOI: 10.1128/Jcm.00634-17  0.475
2017 Courtney CR, Mayr L, Nanfack AJ, Banin AN, Tuen M, Pan R, Jiang X, Kong XP, Kirkpatrick AR, Bruno D, Martens CA, Sykora L, Porcella SF, Redd AD, Quinn TC, ... Nyambi PN, et al. Contrasting antibody responses to intrasubtype superinfection with CRF02_AG. Plos One. 12: e0173705. PMID 28288209 DOI: 10.1371/Journal.Pone.0173705  0.577
2017 Balasubramanian P, Kumar R, Williams C, Itri V, Wang S, Lu S, Hessell AJ, Haigwood NL, Sinangil F, Higgins KW, Liu L, Li L, Nyambi P, Gorny MK, Totrov M, et al. Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination. Vaccine. PMID 28185743 DOI: 10.1016/J.Vaccine.2016.11.107  0.573
2015 Courtney CR, Agyingi L, Fokou A, Christie S, Asaah B, Meli J, Ngai J, Hewlett I, Nyambi PN. Monitoring HIV-1 Group M Subtypes in Yaoundé, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection. Aids Research and Human Retroviruses. PMID 26681241 DOI: 10.1089/Aid.2015.0286  0.513
2015 Noubiap JJ, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN. Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade. Plos One. 10: e0137375. PMID 26371878 DOI: 10.1371/Journal.Pone.0137375  0.516
2015 Li X, Xue Y, Cheng H, Lin Y, Zhou L, Ning Z, Wang X, Yu X, Zhang W, Shen F, Zheng X, Gai J, Li X, Kang L, Nyambi P, et al. HIV-1 Genetic Diversity and Its Impact on Baseline CD4+T Cells and Viral Loads among Recently Infected Men Who Have Sex with Men in Shanghai, China. Plos One. 10: e0129559. PMID 26121491 DOI: 10.1371/Journal.Pone.0129559  0.578
2015 Li L, Wang XH, Williams C, Volsky B, Steczko O, Seaman MS, Luthra K, Nyambi P, Nadas A, Giudicelli V, Lefranc MP, Zolla-Pazner S, Gorny MK. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site. Molecular Immunology. 66: 364-74. PMID 25965315 DOI: 10.1016/J.Molimm.2015.04.011  0.537
2015 Nanfack AJ, Agyingi L, Noubiap JJ, Ngai JN, Colizzi V, Nyambi PN. Use of amplification refractory mutation system PCR assay as a simple and effective tool to detect HIV-1 drug resistance mutations. Journal of Clinical Microbiology. 53: 1662-71. PMID 25788547 DOI: 10.1128/Jcm.00114-15  0.537
2014 Mbondji-Wonje C, Ragupathy V, Zhao J, Nanfack A, Lee S, Torimiro J, Nyambi P, Hewlett IK. Genotypic prediction of tropism of highly diverse HIV-1 strains from Cameroon. Plos One. 9. PMID 25379669 DOI: 10.1371/Journal.Pone.0112434  0.547
2014 Agyingi L, Mayr LM, Kinge T, Orock GE, Ngai J, Asaah B, Mpoame M, Hewlett I, Nyambi P. The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations. Journal of Medical Virology. 86: 385-93. PMID 24248638 DOI: 10.1002/Jmv.23846  0.509
2014 Duerr R, Soni S, Courtney C, Meli J, Ngai J, Mayr L, Nyambi P. Superinfected Patient Pseudovirus Exhibits Resistance to Broadly Neutralizing Antibodies, but Sensitivity to Autologous Plasma Post-superinfection. Aids Research and Human Retroviruses. 30. DOI: 10.1089/Aid.2014.5457A.Abstract  0.555
2014 Courtney C, Mayr L, Nogueira L, Ngai J, Seaman M, Klein F, Nussenzweig M, Nyambi P, Zolla-Pazner S. Investigating Broad Neutralization in HIV-1 Non-B Subtype Infection in Yaoundé, Cameroon. Aids Research and Human Retroviruses. 30. DOI: 10.1089/Aid.2014.5311.Abstract  0.586
2013 Andrabi R, Williams C, Wang XH, Li L, Choudhary AK, Wig N, Biswas A, Luthra K, Nadas A, Seaman MS, Nyambi P, Zolla-Pazner S, Gorny MK. Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals. Virology. 439: 81-8. PMID 23466102 DOI: 10.1016/J.Virol.2012.12.010  0.531
2012 Mayr LM, Powell RL, Ngai JN, Takang WA, Nádas A, Nyambi PN. Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus. Plos One. 7: e38989. PMID 22720009 DOI: 10.1371/Journal.Pone.0038989  0.598
2012 Zhao J, Tang S, Ragupathy V, Gaddam D, Wang X, Zhang P, Nyambi PN, Hewlett I. CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon. Journal of Acquired Immune Deficiency Syndromes. 60: 344-350. PMID 22549382 DOI: 10.1097/Qai.0B013E318258C7E3  0.482
2012 Mayr L, Powell R, Ngai J, Nádas A, Nyambi P. Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus Retrovirology. 9: 72. DOI: 10.1186/1742-4690-9-S2-P72  0.62
2012 Agyingi L, Barengolts D, Mayr L, Kinge T, MBida M, Nyambi P. Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon Retrovirology. 9: 158. DOI: 10.1186/1742-4690-9-S2-P158  0.591
2011 Gorny MK, Sampson J, Li H, Jiang X, Totrov M, Wang XH, Williams C, O'Neal T, Volsky B, Li L, Cardozo T, Nyambi P, Zolla-Pazner S, Kong XP. Human anti-V3 HIV-1 monoclonal antibodies encoded by the VH5-51/VL lambda genes define a conserved antigenic structure. Plos One. 6: e27780. PMID 22164215 DOI: 10.1371/Journal.Pone.0027780  0.459
2011 Ragupathy V, Zhao J, Wood O, Tang S, Lee S, Nyambi P, Hewlett I. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Virology Journal. 8: 185-185. PMID 21513545 DOI: 10.1186/1743-422X-8-185  0.576
2011 Mayr L, Powell R, Kinge T, Nyambi PN. Sequence analysis of the dimerization initiation site of concordant and discordant viral variants superinfecting HIV type 1 patients. Aids Research and Human Retroviruses. 27: 1231-1235. PMID 21453132 DOI: 10.1089/Aid.2011.0010  0.528
2011 Haldar B, Burda S, Williams C, Heyndrickx L, Vanham G, Gorny MK, Nyambi P. Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies. Plos One. 6: e17253. PMID 21383841 DOI: 10.1371/Journal.Pone.0017253  0.577
2011 Tang S, Zhao J, Viswanath R, Nyambi PN, Redd AD, Dastyar A, Spacek LA, Quinn TC, Wang X, Wood O, Gaddam D, Devadas K, Hewlett IK. Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus Type 1-infected blood donors or individuals in Africa Transfusion. 51: 463-468. PMID 21077909 DOI: 10.1111/J.1537-2995.2010.02932.X  0.514
2010 Powell R, Barengolts D, Mayr L, Nyambi P. The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials Viruses. 2: 639-654. PMID 21072143 DOI: 10.3390/V2020639  0.569
2010 Powell RLR, Kinge T, Nyambi PN. Infection by Discordant Strains of HIV-1 Markedly Enhances the Neutralizing Antibody Response against Heterologous Virus Journal of Virology. 84: 9415-9426. PMID 20631143 DOI: 10.1128/Jvi.02732-09  0.618
2010 Tang S, Zhao J, Wang A, Viswanath R, Harma H, Little RF, Yarchoan R, Stramer SL, Nyambi PN, Lee S, Wood O, Wong EY, Wang X, Hewlett IK. Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection. Clinical and Vaccine Immunology : Cvi. 17: 1244-51. PMID 20534793 DOI: 10.1128/Cvi.00066-10  0.601
2010 Powell RLR, Lezeau L, Kinge T, Nyambi PN. Longitudinal Quasispecies Analysis of Viral Variants in HIV Type 1 Dually Infected Individuals Highlights the Importance of Sequence Identity in Viral Recombination Aids Research and Human Retroviruses. 26: 253-264. PMID 20334562 DOI: 10.1089/Aid.2009.0174  0.601
2010 Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, Haldar B, Powell RLR, Jarido V, Hewlett IK, Nyambi PN. HIV‐1 reverse transcriptase drug‐resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon Journal of Medical Virology. 82: 187-196. PMID 20029816 DOI: 10.1002/Jmv.21677  0.505
2009 Ragupathy V, Zhao J, Wang X, Wood O, Lee S, Burda S, Nyambi P, Hewlett I. Comparative analysis of cell culture and prediction algorithms for phenotyping of genetically diverse HIV-1 strains from Cameroon. Aids Research and Therapy. 6: 27-27. PMID 19939258 DOI: 10.1186/1742-6405-6-27  0.421
2009 Powell RLR, Urbanski MM, Burda S, Kinge T, Nyambi PN. High frequency of HIV-1 dual infections among HIV-positive individuals in Cameroon, West Central Africa. Journal of Acquired Immune Deficiency Syndromes. 50: 84-92. PMID 19295338 DOI: 10.1097/Qai.0B013E31818D5A40  0.574
2009 Gorny MK, Wang XH, Williams C, Volsky B, Revesz K, Witover B, Burda S, Urbanski M, Nyambi P, Krachmarov C, Pinter A, Zolla-Pazner S, Nadas A. Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Molecular Immunology. 46: 917-26. PMID 18952295 DOI: 10.1016/J.Molimm.2008.09.005  0.484
2009 Nyambi P, Burda S, Williams C, Heyndrickx L, Vanham G, Gorny M. P04-14. Sequential HIV-1 isolates from infected individuals reveals emergence of neutralization sensitive HIV-1 strains in the course of infection Retrovirology. 6. DOI: 10.1186/1742-4690-6-S3-P42  0.651
2009 Gorny M, Williams C, O'Neal T, Choudhary A, Luthra K, Wood B, Seaman, Nyambi P, Zolla-Pazner S. P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies. Retrovirology. 6: 38. DOI: 10.1186/1742-4690-6-S3-P38  0.339
2009 Powell R, Kinge T, Nyambi P. P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals Retrovirology. 6: 30. DOI: 10.1186/1742-4690-6-S3-P30  0.583
2008 Nyambi P, Burda S, Urbanski M, Heyndrickx L, Janssens W, Vanham G, Nadas A. Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals. Aids Research and Human Retroviruses. 24: 1507-19. PMID 19018670 DOI: 10.1089/Aid.2008.0154  0.581
2008 Powell RLR, Urbanski MM, Nyambi PN. A heteroduplex assay for the rapid detection of dual Human Immunodeficiency Virus Type 1 infections. Journal of Virological Methods. 149: 20-27. PMID 18314205 DOI: 10.1016/J.Jviromet.2008.01.015  0.605
2008 Powell RLR, Urbanski MM, Burda S, Nanfack A, Kinge T, Nyambi PN. Utility of the heteroduplex assay (HDA) as a simple and cost-effective tool for the identification of HIV type 1 dual infections in resource-limited settings. Aids Research and Human Retroviruses. 24: 100-105. PMID 18275354 DOI: 10.1089/Aid.2007.0162  0.529
2007 Powell RL, Zhao J, Konings FA, Tang S, Nanfack A, Burda S, Urbanski MM, Saa DR, Hewlett I, Nyambi PN. Identification of a novel circulating recombinant form (CRF) 36_cpx in Cameroon that combines two CRFs (01_AE and 02_AG) with ancestral lineages of subtypes A and G. Aids Research and Human Retroviruses. 23: 1008-19. PMID 17725418 DOI: 10.1089/Aid.2006.0289  0.47
2007 Powell RL, Zhao J, Konings FA, Tang S, Ewane L, Burda S, Urbanski MM, Saa DR, Hewlett I, Nyambi PN. Circulating recombinant form (CRF) 37_cpx: an old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. Aids Research and Human Retroviruses. 23: 923-33. PMID 17678477 DOI: 10.1089/Aid.2007.0040  0.49
2007 Powell RL, Konings FA, Nanfack A, Burda S, Urbanski MM, Saa D, Nyambi PN. Quasispecies analysis of novel HIV-1 recombinants of subtypes A and G reveals no similarity to the mosaic structure of CRF02_AG. Journal of Medical Virology. 79: 1270-85. PMID 17607774 DOI: 10.1002/Jmv.20937  0.557
2006 Khurana S, Needham J, Park S, Mathieson B, Busch MP, Nemo G, Nyambi P, Zolla-Pazner S, Laal S, Mulenga J, Chomba E, Hunter E, Allen S, McIntyre J, Hewlett I, et al. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. Journal of Acquired Immune Deficiency Syndromes (1999). 43: 304-12. PMID 17019363 DOI: 10.1097/01.Qai.0000242465.50947.5F  0.603
2006 Gorny MK, Williams C, Volsky B, Revesz K, Wang XH, Burda S, Kimura T, Konings FA, Nádas A, Anyangwe CA, Nyambi P, Krachmarov C, Pinter A, Zolla-Pazner S. Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1. Journal of Virology. 80: 6865-72. PMID 16809292 DOI: 10.1128/Jvi.02202-05  0.418
2006 Konings FA, Haman GR, Xue Y, Urbanski MM, Hertzmark K, Nanfack A, Achkar JM, Burda ST, Nyambi PN. Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. Journal of Acquired Immune Deficiency Syndromes (1999). 42: 331-41. PMID 16639350 DOI: 10.1097/01.Qai.0000219784.81163.2E  0.57
2006 Konings FA, Burda ST, Urbanski MM, Zhong P, Nadas A, Nyambi PN. Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G. Journal of Medical Virology. 78: 523-34. PMID 16555291 DOI: 10.1002/Jmv.20572  0.571
2006 Kelly HR, Urbanski M, Burda S, Zhong P, Konings F, Nanfack J, Tongo M, Kinge T, Achkar J, Nyambi P. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals. Human Antibodies. 14: 89-99. DOI: 10.3233/Hab-2005-143-406  0.526
2005 Kelly HR, Urbanski M, Burda S, Zhong P, Konings F, Nanfack J, Tongo M, Kinge T, Achkar J, Nyambi P. Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals. Human Antibodies. 14: 89-99. PMID 16720979  0.499
2005 Ma L, Marmor M, Zhong P, Ewane L, Su B, Nyambi P. Distribution of CCR2-64I and SDF1-3'A alleles and HIV status in 7 ethnic populations of Cameroon. Journal of Acquired Immune Deficiency Syndromes (1999). 40: 89-95. PMID 16123688 DOI: 10.1097/01.Qai.0000157008.66584.D6  0.557
2005 Sivapalasingam S, Essajee S, Nyambi PN, Itri V, Hanna B, Holzman R, Valentine F. Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: implications for resource-limited settings. Journal of Clinical Microbiology. 43: 3793-6. PMID 16081912 DOI: 10.1128/Jcm.43.8.3793-3796.2005  0.538
2005 Krachmarov C, Pinter A, Honnen WJ, Gorny MK, Nyambi PN, Zolla-Pazner S, Kayman SC. Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking. Journal of Virology. 79: 780-90. PMID 15613306 DOI: 10.1128/Jvi.79.2.780-790.2005  0.455
2004 Burda ST, Konings FA, Williams CA, Anyangwe C, Nyambi PN. HIV-1 CRF09_cpx circulates in the North West Province of Cameroon where CRF02_AG infections predominate and recombinant strains are common. Aids Research and Human Retroviruses. 20: 1358-63. PMID 15650429 DOI: 10.1089/Aid.2004.20.1358  0.559
2004 Zolla-Pazner S, Zhong P, Revesz K, Volsky B, Williams C, Nyambi P, Gorny MK. The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1. Aids Research and Human Retroviruses. 20: 1254-8. PMID 15588347 DOI: 10.1089/Aid.2004.20.1254  0.537
2004 Konings FA, Nyambi PN. V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon. Aids Research and Human Retroviruses. 20: 673-8. PMID 15242545 DOI: 10.1089/0889222041217464  0.475
2004 Achkar JM, Burda ST, Konings FA, Urbanski MM, Williams CA, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi PN. Infection with HIV type 1 group M non-B subtypes in individuals living in New York City. Journal of Acquired Immune Deficiency Syndromes (1999). 36: 835-44. PMID 15213568 DOI: 10.1097/00126334-200407010-00011  0.55
2004 Njai HF, Auwera GVd, Ngong CA, Heyndrickx L, Sawadago S, Whittle H, Nyambi P, Colebunders R, Groen Gvd, Janssens W. Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG. Journal of Clinical Microbiology. 42: 1428-1433. PMID 15070984 DOI: 10.1128/Jcm.42.4.1428-1433.2004  0.498
2004 Konings FA, Zhong P, Agwara M, Agyingi L, Zekeng L, Achkar JM, Ewane L, Saa, Afane Ze E, Kinge T, Nyambi PN. Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon. Aids Research and Human Retroviruses. 20: 105-9. PMID 15008125 DOI: 10.1089/088922204322749558  0.382
2004 Nádas A, Zhong P, Burda S, Zekeng L, Urbanski M, Gorny MK, Zolla-Pazner S, Nyambi PN. Defining Human Immunodeficiency Virus (HIV) Type 1 Immunotypes with Six Human Monoclonal Antibodies Aids Research and Human Retroviruses. 20: 55-65. PMID 15000699 DOI: 10.1089/088922204322749503  0.608
2004 Gorny MK, Revesz K, Williams C, Volsky B, Louder MK, Anyangwe CA, Krachmarov C, Kayman SC, Pinter A, Nadas A, Nyambi PN, Mascola JR, Zolla-Pazner S. The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. Journal of Virology. 78: 2394-404. PMID 14963135 DOI: 10.1128/Jvi.78.5.2394-2404.2004  0.421
2003 Zhong P, Burda S, Konings F, Urbanski M, Ma L, Zekeng L, Ewane L, Agyingi L, Agwara M, Saa, Ze E A, Kinge T, Zolla-Pazner S, Nyambi P. Genetic and Biological Properties of HIV Type 1 Isolates Prevalent in Villagers of the Cameroon Equatorial Rain Forests and Grass Fields: Further Evidence of Broad HIV Type 1 Genetic Diversity Aids Research and Human Retroviruses. 19: 1167-1178. PMID 14717120 DOI: 10.1089/088922203771881284  0.615
2003 Zhong P, Kang L, Pan Q, Konings F, Burda S, Ma L, Xue Y, Zheng X, Jin Z, Nyambi P. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance -- associated mutations in Shanghai P.R. China. Journal of Acquired Immune Deficiency Syndromes. 34: 91-101. PMID 14501800 DOI: 10.1097/00126334-200309010-00014  0.582
2002 Nyambi P, Zekeng L, Kenfack H, Tongo M, Nanfack A, Nkombe I, Ndonko F, Shang J, Burda S, Mbah H, Agyingi L, Zhong P, Nádas A, Zolla-Pazner S, Marmor M. HIV infection in rural villages of Cameroon Journal of Acquired Immune Deficiency Syndromes. 31: 506-513. PMID 12473839 DOI: 10.1097/00126334-200212150-00008  0.565
2002 Zhong P, Burda S, Urbanski M, Kenfack H, Tongo M, Heyndrickx L, Nanfack A, Shang J, Agyingi L, Zolla-Pazner S, Zekeng L, Nyambi P. HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon Journal of Acquired Immune Deficiency Syndromes. 31: 495-505. PMID 12473838 DOI: 10.1097/00126334-200212150-00007  0.548
2002 Nyambi P, Heyndrickx L, Vereecken K, Burda S, Houwer KD, Coppens S, Urbanski M, Williams C, Ndumbe P, Janssens W. Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns. Aids. 16: 295-296. PMID 11807317 DOI: 10.1097/00002030-200201250-00022  0.554
2001 Mbah HA, Burda S, Gorny MK, Williams C, Revesz K, Zolla-Pazner S, Nyambi PN. Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades Journal of Virology. 75: 7785-7788. PMID 11462056 DOI: 10.1128/Jvi.75.16.7785-7788.2001  0.387
2001 Nyambi PN, Burda S, Bastiani L, Williams C. A virus binding assay for studying the antigenic landscape on intact, native, primary human immunodeficiency virus-type 1. Journal of Immunological Methods. 253: 253-262. PMID 11384686 DOI: 10.1016/S0022-1759(01)00384-2  0.541
2001 York J, Follis KE, Trahey M, Nyambi PN, Zolla-Pazner S, Nunberg JH. Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1 Journal of Virology. 75: 2741-2752. PMID 11222697 DOI: 10.1128/Jvi.75.6.2741-2752.2001  0.563
2000 Nyambi PN, Nadas A, Mbah HA, Burda S, Williams C, Gorny MK, Zolla-Pazner S. Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes Journal of Virology. 74: 10670-10680. PMID 11044111 DOI: 10.1128/Jvi.74.22.10670-10680.2000  0.636
2000 Achkar JM, Wang XH, Nyambi P, Gorny MK, Zolla-Pazner S, Bandrés JC. Polymerase chain reaction-based assay for antibody-mediated neutralization of HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay Journal of Acquired Immune Deficiency Syndromes. 24: 203-210. PMID 10969343 DOI: 10.1097/00126334-200007010-00002  0.623
2000 Beirnaert E, Nyambi P, Willems B, Heyndrickx L, Colebunders R, Janssens W, Groen Gvd. Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. Journal of Medical Virology. 62: 14-24. PMID 10935983 DOI: 10.1002/1096-9071(200009)62:1<14::Aid-Jmv3>3.0.Co;2-L  0.576
2000 Nyambi PN, Mbah HA, Burda S, Williams C, Gorny MK, Nádas A, Zolla-Pazner S. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M Journal of Virology. 74: 7096-7107. PMID 10888650 DOI: 10.1128/Jvi.74.15.7096-7107.2000  0.523
1999 Zolla-Pazner S, Gomy MK, Nyambi PN. The implications of antigenic diversity for vaccine development Immunology Letters. 66: 159-164. PMID 10203049 DOI: 10.1016/S0165-2478(98)00176-X  0.556
1999 Zolla-Pazner S, Gorny MK, Nyambi PN, VanCott TC, Nádas A. Immunotyping of human immunodeficiency virus type 1 (HIV): An approach to immunologic classification of HIV Journal of Virology. 73: 4042-4051. PMID 10196300 DOI: 10.1128/Jvi.73.5.4042-4051.1999  0.576
1998 Nyambi PN, Gorny MK, Bastiani L, Van Der Groen G, Williams C, Zolla-Pazner S. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: A new strategy for studying the immunologic relatedness of HIV-1 Journal of Virology. 72: 9384-9391. PMID 9765494 DOI: 10.1128/Jvi.72.11.9384-9391.1998  0.594
1998 Cecilia D, Kewalramanl VN, O'Leary J, Volsky B, Nyambi P, Burda S, Xu S, Littman DR, Zolla-Pazner S. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage Journal of Virology. 72: 6988-6996. PMID 9696790 DOI: 10.1128/Jvi.72.9.6988-6996.1998  0.554
Show low-probability matches.